Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - erlotinibklorid - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 100 mg erlotiniba u obliku erlotinibklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - erlotinibklorid - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 150 mg erlotiniba u obliku erlotinibklorida

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

alkaloid d.o.o. sarajevo - erlotinib - film tableta - 100 mg/1 tableta - jedna film tableta sadrži 100 mg erlotiniba (što odgovara 109,29 mg erlotinibhidrohlorida).

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

alkaloid d.o.o. sarajevo - erlotinib - film tableta - 150 mg/1 tableta - jedna film tableta sadrži 150 mg erlotiniba (što odgovara 163,94 mg erlotinibhidrohlorida).

Europska Unija - hrvatski - EMA (European Medicines Agency)

ucb pharma s.a. - romosozumab - osteoporoza - lijekovi za liječenje bolesti kostiju - evenity je naznačeno u liječenju teških oblika osteoporoze kod postmenopauzalnih žena sa visokim rizikom od frakture.

Europska Unija - hrvatski - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hidroklorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresivi - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Europska Unija - hrvatski - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - multipla skleroza - ostali lijekovi protiv živčanog sustava - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Europska Unija - hrvatski - EMA (European Medicines Agency)

teva gmbh - dimetil fumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Europska Unija - hrvatski - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetil fumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Europska Unija - hrvatski - EMA (European Medicines Agency)

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.